Yuhan Corporation
Clinical trials sponsored by Yuhan Corporation, explained in plain language.
Yuhan Corporation
000100
KRX
A South Korean pharmaceutical company developing drugs and vaccines.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New generic combo pill for high blood pressure put to the test Results expected Sep 2026 (estimated)
- Healthy men needed to test experimental Drug's safety Results expected Mar 2027 (estimated)
- New drug YH32364 targets Hard-to-Treat cancers in first human trial Results expected Jun 2027 (estimated)
- New hope for chronic hives? experimental drug lesigercept enters Mid-Stage trial Results expected Jun 2027 (estimated)